RCUS — Arcus Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Arcus Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	499	1,009	759	978	981
Net Total Accounts Receivable
Net Total Receivables	747	39	42	25	16
Prepaid Expenses
Total Current Assets	1,262	1,067	831	1,016	1,007
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	137	135	143	112	98
Long Term Investments
Other Long Term Assets
Total Assets	1,592	1,345	1,095	1,150	1,139
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	166	193	184	226	231
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	750	688	633	665	508
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	841	657	462	485	631
Total Liabilities & Shareholders' Equity	1,592	1,345	1,095	1,150	1,139
Total Common Shares Outstanding